| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 Subunit–Deficient Mice
Interdepartmental PhD Program for Neuroscience and Departments of Neurology and Physiology, David Geffen School of Medicine at the University of California, Los Angeles, California
Submitted 24 October 2005; accepted in final form 30 January 2006
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
-aminobutyric acid receptor (GABAR)–mediated inhibition can be classified as phasic (synaptic) and tonic (extrasynaptic). The GABARs underlying tonic inhibition assemble from subunits different from those responsible for phasic inhibition. We wanted to assess the excitability of hippocampal pyramidal cell (PC) networks following a selective impairment of tonic inhibition. This is difficult to accomplish by pharmacological means. Because the GABAR 
5 subunits mostly mediate the tonic inhibition in CA1 and CA3 PCs, we quantified changes in tonic inhibition and examined network excitability in slices of adult gabra5–/– mice. In gabra5–/– CA1 and CA3 PCs tonic inhibitory currents were 60 and 53%, respectively, of those recorded in wild type (WT), with no alterations in phasic inhibition. The amount of tonic inhibition recorded in slices was significantly affected by the method of slice storage (interface or submerged chamber). Field recordings in gabra5–/– CA3 pyramidal layer showed an increased network excitability that was decreased by the GABAR agonist muscimol at a concentration that restored the tonic inhibition of gabra5–/– PCs to the WT level without altering phasic inhibition. Through a battery of pharmacological experiments, we have identified 
subunit–containing GABARs as the mediators of the residual tonic inhibition in gabra5–/– PCs. Our study is consistent with an important role of tonic inhibition in the control of hippocampal network excitability and highlights selective enhancers of tonic inhibition as promising therapeutic approaches for diseases involving network hyperexcitability. |
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
-Aminobutyric acid receptors (GABARs) are ligand-gated Cl– channels mediating most of chemical inhibitory activity in the brain. These receptors are pentameric assemblies of seven different subunit classes: (1–6), 
(1–3), (1–3), , 
, 
, and 
(1–3) (Hevers and Lüddens 1998
; Sieghart and Sperck 2002). Functionally, GABARs can be classified as mediating phasic or tonic inhibition (Farrant and Nusser 2005; Mody 2001; Semyanov et al. 2004). Phasic inhibition is mediated by GABARs localized at synapses, whereas tonic inhibition arises from activation of extrasynaptic receptors by low concentrations of ambient GABA (Farrant and Nusser 2005; Mody 2001; Semyanov et al. 2004). These two types of inhibition have been identified in cerebellar granule cells (Brickley et al. 1996; Rossi et al. 2003), dentate gyrus granule cells (Nusser and Mody 2002; Stell and Mody 2002), CA1 pyramidal cells (PCs), and interneurons (Bai et al. 2001; Caraiscos et al. 2004; Semyanov et al. 2003). Extrasynaptic GABARs outnumber those found at synapses (Nusser et al. 1995) and have been suggested to sense GABA spillover (Banks and Pearce 2000; Wei et al. 2003). The different properties of extrasynaptic and synaptic receptors are thought to result from either different subunit composition (Nusser and Mody 2002; Stell and Mody 2002) or from a differential regulation by second messengers (Banks and Pearce 2000).
Phasic inhibition can be selectively enhanced (Nusser and Mody 2002) or decreased (Stell and Mody 2002) by pharmacological means without altering tonic inhibition. In contrast, pharmacological tools are available for specifically enhancing tonic inhibition (Stell et al. 2003; Wallner et al. 2003; Wei et al. 2004), but not for its selective decrease without affecting spontaneous inhibitory currents (Semyanov et al. 2003). Nevertheless, we wanted to study the effects of a selective reduction in tonic inhibition on the excitability of CA1 and CA3 PC networks, the latter having a particularly low threshold for seizure generation (Colom and Saggau 1994; Nagao et al. 1996). Therefore we carried out quantitative measurements of tonic and phasic inhibitions and of network excitability in adult gabra5–/– mice known to have a deficit in tonic inhibition (Caraiscos et al. 2004).
The GABAR 5 subunit has a restricted distribution in the rodent brain. It is primarily found in dendritic areas (strata radiatum, oriens/lacunosum moleculare) of hippocampal CA1 and CA3 regions (Fritschy and Möhler 1995; Pirker et al. 2000; Sur et al. 1999; Wisden et al. 1992). In addition, this subunit is thought to contribute almost exclusively to the extrasynaptic GABAR pool of PCs (Brünig et al. 2002; Caraiscos et al. 2004). Inhibition mediated by 5 subunit–containing receptors has been shown to be involved in learning and memory (Collinson et al. 2002), trace fear conditioning (Crestani et al. 2002), generation of gamma oscillations (Towers et al. 2004), as well as in epilepsy (Houser and Esclapez 2003; Rice et al. 1996; Scimemi et al. 2005). In young (P18–P23) gabra5–/– mice, CA1 PCs appear to be devoid of tonic GABA currents (Caraiscos et al. 2004). Such a selective involvement of GABAR subunits in tonic inhibition has been shown only for subunit–containing receptors (Stell et al. 2003) that have a relatively late development (Laurie et al. 1992).
We further investigated the selective decrease of tonic inhibition in adult gabra5–/– mouse hippocampal slices and found a reduction, not a total loss, of tonic inhibition in both CA1 and CA3 PCs, without any alteration in phasic inhibition. This selective decrease in tonic inhibition led to epileptiform hyperexcitability in the CA3 pyramidal layer, which could be rescued by restoring tonic inhibition to levels observed in wild-type (WT) PCs. Pharmacological studies using specific modulators of tonic inhibition are consistent with a homeostatic upregulation of subunits in gabra5–/– mice responsible for the residual tonic current observed in gabra5–/– PCs.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
This study mainly used adult male (1–4 mo old) C57/Bl6, gabra5–/–, and gabra5+/+ littermates, but young (18 days old) gabra5–/– animals were also studied. The gabra5–/– and WT littermates were raised from heterozygous breeding pairs kindly provided by Merck, Sharp & Dohme (Harlow, UK) and were bred at the UCLA Division of Laboratory Animal Medicine. Mice were anesthetized with halothane according to a protocol approved by the UCLA Chancellor's Animal Research Committee. The brain was removed and placed in ice-cold artificial cerebrospinal fluid (aCSF) containing (in mM): 126 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose with pH 7.3–7.4 when bubbled with 95% O2-5% CO2. Brain slices, 350 µm thick, were cut with a Leica VT1000S Vibratome (Leica Microsystems, Wetzlar, Germany) in aCSF containing 3 mM kynurenic acid (Sigma, St. Louis, MO). Coronal slices were prepared for CA1 PC whole cell recordings, whereas CA3 PC recordings were obtained in horizontal slices. The CA3 and CA1 regions were surgically disconnected for field recording studies to prevent CA3 from driving the activity in CA1. Slices were stored at 32°C for 
1 h either in a submerged [tetrahydrodeoxycorticosterone (THDOC) experiments] or an interface chamber (for the rest of experiments) before being transferred to the recording chamber.
Whole cell recordings
CA1 and CA3 PCs were visually identified (Olympus, Melville, NY; BX51WI, IR-DIC videomicroscopy; 40 x water immersion objective) and recorded with an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). Slices were continuously perfused (about 2.5 ml/min) at 32–34°C with 95% O2-5% CO2 bubbled aCSF containing kynurenic acid (3 mM) and other drugs as indicated. Microelectrodes (1–5 M
when filled) contained the following internal solution (in mM): 140 CsCl, 1 MgCl2, 10 HEPES, 0.1 EGTA, 4 NaCl, 2 MgATP, and 5 QX-314, pH 
7.25, about 285 mOsm. Whole cell voltage-clamp recordings were performed at –70 mV holding potential. Series resistance and whole cell capacitance were estimated from fast transients evoked by a 5-mV voltage command step using lag values of 7–10 µs and then compensated to 70–80%. Recordings were discontinued if series resistance increased by >25% through an experiment, or the compensated resistance surpassed 20 M at any time during the experiment.
Extracellular field recordings
Simultaneous recordings were made in CA1 and CA3 pyramidal layers in slices held at 32–34°C in a 95% O2-5% CO2 aerated interface chamber and perfused with aCSF saturated with 95% O2-5% CO2 (flow rate 2.5 ml/min). Signal amplification was achieved by a custom-made 100X headstage connected to a DC amplifier (Model 440; Brownlee Precision, San Jose, CA). Recording pipettes were filled with aCSF and had resistances of about 5 M.
Drugs
GABA (Sigma) at a concentration of 5 µM was added to the aCSF where indicated and slices were preincubated in this solution for 10 min before starting whole cell recordings. We first determined whether the 5 µM GABA is the real concentration activating the GABA receptors responsible for tonic inhibition when perfused onto brain slices. In CA1 PCs of C57/Bl6 mice perfused with aCSF containing 5 µM GABA the tonic current increased to 195% of control, from 22.5 ± 4.6 to 43.9 ± 3.1 pA (n = 5; P = 0.006; paired t-test), on addition of the GAT-1 GABA uptake blocker NO-711 (10 µM). This finding indicates that active GABA transport/degradation mechanisms remove a large part of the externally added GABA. Thus the final concentration of ambient GABA in our brain slices is considerably <5 µM, probably close to the physiological GABA levels measured in the extracellular space by microdialysis in the hippocampus (range 0.2–2.5 µM obtained from pooled values of Ding et al. 1998; Lerma et al. 1986; Tossman et al. 1986). Unless indicated otherwise, tonic currents were recorded in aCSF with 5 µM GABA added to standardize the ambient GABA levels around the recorded neurons, which might otherwise vary with the depth of the neuron in the slice, the level of local spontaneous GABA release, and uptake or other unknown factors.
Stock solutions of THDOC (Sigma) were prepared in 100% ethanol and added to the aCSF where indicated (final concentration: 100 nM THDOC, 0.002% ethanol). Diazepam (DZP) was dissolved in 100% dimethylsulfoxide (DMSO) and added where indicated (final concentration: 0.5 µM, 0.05% DMSO). Muscimol (Fluka, St. Louis, MO) and 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol hydrochloride(THIP, Tocris Cookson, Ellisville, MO) were added to the aCSF where indicated. Bicuculline methiodide (BMI, 20 µl of 10 mM stock solution; Sigma) was injected directly into the recording chamber (final concentration 200 µM) to reveal tonic currents. CdCl2 (50 µM) was dissolved in aCSF to record miniature inhibitory postsynaptic currents (mIPSCs).
Data acquisition and analysis
All recordings were low-pass filtered at 3 kHz and digitized on-line at 10 kHz using a PCI-MIO 16E-4 data-acquisition board (National Instruments, Austin, TX). Spontaneous field activity was detected using a custom-written LabView-based software.
decay) values were measured. IPSCslow was defined as any sIPSC with an RT10–90 >1.5 ms. The ratio of IPSCslow over total number of events (Rslow/total) was determined by dividing the frequency of IPSCslow by the frequency of total sIPSCs. Average data are shown as mean ± SE. Statistical significance was assessed by unpaired t-test assuming unequal variances, and by two-way and one-way ANOVAs with a Tukey test for multiple comparisons. To perform ANOVA tests between a pharmacological experimental group and their respective controls, we took a random sample of cells from the respective gabra5+/+ or gabra5–/– control group (columns 1 or 2 of Table 1), equivalent in number to the cells in the pharmacological experiment. The level of significance was set at P < 0.05. 
2 test and by Wilcoxon matched-pairs signed-ranks test; the level of significance was set at P < 0.05.
|
|
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
Tonic currents recorded in CA1 PCs of C57/Bl6 and gabra5+/+ brain slices stored in a submerged chamber before recordings were not statistically different (C57/Bl6 23.2 ± 3.51 pA, n = 9; gabra5+/+ 27.6 ± 5.18, n = 7; P = 0.45, unpaired t-test); therefore the two groups were pooled together and designated as WT (25.1 ± 2.71 pA, n = 16). The average input resistance in control conditions was 111.7 ± 4.73 M compared with 125.8 ± 3.9 M in the presence of BMI (n = 16, P < 0.01, paired t-test). CA1 PCs of gabra5–/– slices did not show a complete absence of tonic current because a reduced tonic current (60% of control) could still be recorded in these cells that was statistically different from the one recorded in WT (gabra5–/– 15.1 ± 1.82 pA, n = 16; P < 0.01, unpaired t-test; Fig. 1, A and C). In these cells, the input resistances were not significantly different between control and BMI conditions (113.4 ± 6.67 M vs. 119.4 ± 5.9 M; n = 14, P > 0.05, paired t-test). Similar results were found in gabra5–/– CA3 PCs with a residual tonic current (53% of control) that was significantly smaller than that recorded in C57/Bl6 CA3 PCs (C57/Bl6 30.1 ± 5.28 pA, n = 8 vs. gabra5–/– 16.1 ± 2.89 pA, n = 4; P < 0.05, unpaired t-test; Fig. 2).
|
). We wanted to compare recordings from slices stored in a modified interface incubating chamber to those stored in a submerged chamber. Tonic currents recorded in CA1 PCs of slices stored in the interface chamber for 1–3 h were larger than those recorded in slices stored in a submerged chamber. Nevertheless, the tonic currents of gabra5–/– PCs were still statistically reduced (53% of control) compared with gabra5+/+ (gabra5+/+ 43.5 ± 3.30 pA, n = 12 vs. gabra5–/– 23.1 ± 1.75 pA, n = 17; P < 0.001, unpaired t-test; Fig. 1, B and C). A two-factor ANOVA between 12 randomly selected samples from WT and gabra5–/– PCs in both incubating conditions showed a significant genotype effect regardless of the incubation condition (P = 4 x 10–6, df = 1), a significant effect of the incubation condition regardless of the genotype (P = 1.1 x 10–5, df = 1) and an interaction between genotype and incubation condition (P = 0.019, df = 1). The tonic currents recorded in WT PCs in submerged versus interface chamber were significantly different (P = 3.6 x 10–5, one-way ANOVA, Tukey test) but those in gabra5–/– PCs were similar between both incubation conditions (P = 0.29, one-way ANOVA, Tukey test). In other words, the incubation condition affected more the tonic inhibition recorded in WT than in gabra5–/– PCs.
Regardless of the incubation condition, there was a residual tonic current in the absence of GABAR 5 subunits. These results are in contrast to those of Caraiscos et al. (2004) in CA1 PCs, where the loss of 5 subunits was paralleled by a total loss of tonic currents. One difference between the two experimental approaches is that we used steady levels of extracellular GABA (5 µM) to reveal tonic currents instead of enhancing extracellular GABA levels by blocking GABA transaminase by vigabatrin (Caraiscos et al. 2004). Another reason could have been that we used adult mice (1–4 mo old), whereas younger mice (P18–P23) were used in the previous study (Caraiscos et al. 2004). As other GABAR subunits such as the start being expressed at a later developmental stage (after P12; Laurie et al. 1992) than 5 subunits (P1–P7; Ramos et al. 2004), compensatory mechanisms by subunits may not be in place until later in development. To test this, we performed experiments in P18 gabra5–/– CA1 PCs in the presence of 5 µM GABA. A residual tonic current of 22.7 ± 1.30 pA (n = 4) was still present in these slices. These results suggest that even at a very young age there is still a residual tonic current in gabra5–/– CA1 PCs. Even in the absence of GABA in the aCSF a residual tonic current was still present in adult gabra5–/– CA1 PCs (13.9 ± 5.55 pA, n = 3).
Phasic inhibition is unaltered in the absence of 5 subunits
Phasic inhibition is mediated by synaptic GABARs (Mody 2001; Semyanov et al. 2004). Because the 5 subunit is known to be localized mostly extrasynaptically in CA1 and CA3 PCs (Brünig et al. 2002), phasic inhibition is not expected to be altered in the absence of these subunits. However, reduced mean peak sIPSC amplitudes recorded at 22°C have been reported in brain slices prepared from P14–P32 gabra5–/– mice (Collinson et al. 2002). We also examined whether the absence of 5 subunits alters sIPSCs by recording sIPSCs in gabra5+/+ and gabra5–/– CA1 PCs of adult mouse brain slices stored in either a submerged or an interface chamber. In the presence of 3 mM kynurenic acid and 5 µM GABA, the mean frequency of sIPSCs, peak amplitudes, RT10–90, and decay were similar between gabra5–/– and gabra5+/+ mice and also did not show an effect of the incubating condition (two-way ANOVA, P > 0.05, df = 1, n = 12, the same randomly selected cells used to compare the tonic currents; Table 1, Fig. 3). sIPSCs frequency and kinetics recorded in C57/Bl6 and gabra5–/– CA3 PCs were also not statistically different (P > 0.05, unpaired t-test; Table 1). We followed up these experiments by examining mIPSCs in CA1 PCs of the two genotypes using CdCl2 (50 µM) to block presynaptic Ca2+ entry. There were no statistical differences in the frequency, peak amplitude, RT10–90, or decay of mIPSCs between C57/Bl6 and gabra5–/– slices (P > 0.05 for each parameter, unpaired t-test; Table 1 and Fig. 3). The most plausible explanation for these results is that 5 subunits, even if present at synapses, do not shape the synaptic currents and, consequently, there are no synaptic compensatory mechanisms when this subunit is deleted. If indeed 5 subunits are present at synapses, they may be in a desensitized state or may form heteromeric GABARs with other subunits, thus overriding the specific properties of 5 subunits.
|
IPSCslow have been reported in CA1 PCs in mature rats (Banks et al. 2002), with severalfold slower kinetics than that of IPSCfast (Banks and Pearce 1998; Pearce 1993). To determine whether IPSCslow events in CA1 PCs are attributed to spillover of GABA to extrasynaptic 5 subunit–containing receptors, we compared slow sIPSCs in CA1 and CA3 PCs of WT and gabra5–/– brain slices (Fig. 4A). We did not find a statistical difference in event kinetics between the two groups (Table 2 and Fig. 4B), although there was a statistical difference in the frequency of slow events (WT: frequency 3.22 ± 0.28 Hz, n = 11; gabra5–/–: frequency 2.40 ± 0.21 Hz, n = 11; P < 0.05, unpaired t-test, Table 2) as well as in the Rslow/total (WT: 0.13 ± 0.01, n = 11 and gabra5–/–: 0.09 ± 0.01, n = 11; P < 0.05, unpaired t-test; 31% reduction; Table 2 and Fig. 4C). When CA3 PCs were compared between the two genotypes, there were no statistical differences in kinetics and in frequency of events (Table 2 and Fig. 4B). Nonetheless, there was a significant 27% reduction in Rslow/total (C57/Bl6: 0.15 ± 0.01, n = 7 and gabra5–/–: 0.11 ± 0.01, n = 6; P < 0.05, unpaired t-test; Table 2 and Fig. 4C), suggesting that at least a fraction of IPSCslow events in the WT result from GABA spillover onto 5 extrasynaptic receptors. The charge mediated by IPSCslow events in C57/Bl6 CA3 PCs was1.17 pC, representing a mere 2.9% of the total inhibitory charge (40.4 pC) of which 74.5% is mediated by the tonic current. In gabra5–/– slices IPSCslow events carried a charge of 1.05 pC corresponding to 3.6% of the total inhibitory charge (29.3 pC), of which only 54.8% was mediated by tonic inhibition. Similar results were found in CA1 PCs.
|
|
At this time there are no specific pharmacological blockers of tonic inhibition that will be without effect on phasic currents (Semyanov et al. 2003). Lanthanum has been shown to block GABARs responsible for tonic inhibition (Saxena et al. 1997; Shen et al. 2005), although this cation also has significant effects on synaptic transmission and other cellular events. Therefore the nearly 44% decrease in tonic inhibition in CA1 PCs and the 47% decrease in CA3 PCs with no change in phasic inhibition provide an ideal setting to study the effects of a specific reduction in tonic inhibition on neuronal excitability. To study these two regions independently and to prevent the possibility of the CA3 PCs driving the activity in the CA1 region, we surgically disconnected the two regions at the time the slices were prepared. The aCSF used in these experiments contained neither kynurenic acid nor GABA to record the full excitability of the system. Field recordings in the CA1 pyramidal layer of C57/Bl6 and gabra5–/– slices showed no spontaneous activity (n = 12 and n = 9, respectively). In contrast, spontaneous activity could be recorded in the CA3 region. Spontaneous single-population spikelike events were recorded in both C57/Bl6 and gabra5–/– CA3 regions (C57/Bl6 5/12 slices vs. gabra5–/– 4/9 slices, 2 test, P > 0.05, df = 1). Interestingly, CA3 gabra5–/– slices showed spontaneous epileptiform bursts in five of nine slices with a mean interevent interval of 0.45 ± 0.12 s, mean number of spikes/burst of 2.76 ± 0.71 (n = 3), and a power spectrum peak at 200 Hz (Fig. 5). Such spontaneous bursts were never seen in slices of C57/Bl6 animals unless higher concentrations of extracellular K+ (3 mM) and lower concentrations of Mg2+ (1.8 mM) and Ca2+ (1.6 mM) are used (Maier et al. 2003). Our results show that selectively reducing tonic inhibition by half in the CA3 region is sufficient to permit the occurrence of epileptiform bursts with a relatively high frequency (2.2 Hz) in spite of the full activity of phasic inhibition.
|
The GABAR subunit, which begins expression during late development (Laurie et al. 1992), has been shown to mediate tonic currents in both dentate gyrus and in cerebellar granule cells but not in CA1 PCs (Stell et al. 2003; Wei et al. 2004). Muscimol, a GABAA receptor agonist, at low concentrations probably binds specifically to the subunit–containing GABARs because there is no [3H]muscimol binding in the brains of gabrd–/– mice (Mihalek et al. 1999). Therefore we wanted to determine whether muscimol at low concentration (25 nM) in a 5 µM GABA–containing aCSF had any specific effects on tonic inhibition. A two-way ANOVA in seven randomly selected cells in each group showed that the effect of muscimol depended on genotype (P = 0.004, df = 1). Muscimol (25 nM) increased tonic currents only in gabra5–/– CA1 PCs, while not affecting those recorded in gabra5+/+ CA1 PCs (gabra5+/+ control 45.8 ± 4.46 pA vs. gabra5+/+ muscimol 48.8 ± 2.88 pA, P = 0.9734; gabra5–/– control 23.1 ± 3.70 pA vs. gabra5–/– muscimol 57.0 ± 7.24 pA, P = 0.0003; one-way ANOVA, Tukey test; Fig. 6, A and B). Frequency and kinetics of sIPSCs were not altered by this low concentration of muscimol regardless of genotype (one-way ANOVA for each parameter between the same randomly selected cells used in the tonic analysis, P > 0.05, df = 1; Fig. 6, C and D, Table 3) and the drug did not show an interaction with the genotype (two-way ANOVA, P > 0.05, df = 1, for frequency, peak amplitude, RT10–90, and decay, between the same randomly selected cells used in the tonic analysis). These results show that 25 nM muscimol selectively increases the residual tonic currents of gabra5–/– PCs to wild-type levels without altering phasic inhibition.
|
|
|
subunit is responsible for the residual tonic current in gabra5–/– CA1 pyramidal cells
Tonic inhibition in many neurons is mediated by GABARs containing 4 (or 6) and subunits highly sensitive to modulation by low, physiological concentrations of neurosteroids such as THDOC (Stell et al. 2003). We therefore wanted to consider the possibility that the residual tonic current seen in gabra5–/– PCs was mediated by such GABARs. Recordings were performed in the presence or absence of 100 nM THDOC (submerged incubation). In gabra5+/+ CA1 PCs the THDOC induced change in tonic inhibition was not significant (THDOC group 40.4 ± 6.23 pA, n = 5 vs. control 25.1 ± 2.71, n = 16; P = 0.091, one-way ANOVA; Fig. 8A). A lack of THDOC effect on tonic currents in gabra5+/+ mice is consistent with our previous findings showing that CA1 PCs are insensitive to this concentration of THDOC (Stell et al. 2003). In contrast, gabra5–/– CA1 PCs showed a significant increase (257% of control) of the residual tonic current in the presence of THDOC (THDOC group 38.8 ± 7.21 pA, n = 8, vs. control 15.1 ± 1.82 pA, n = 16; P = 0.0004, one-way ANOVA; Fig. 8B). Frequency and kinetics of sIPSCs were not altered by THDOC in any of the two genotypes when compared with control conditions (one-way ANOVA for each sIPSC parameter, P > 0.05; Table 3). We also wanted to address the contribution of subunit–containing GABARs to IPSCslow by comparing the kinetics and frequency of slow events in gabra5–/– CA1 PCs when exposed to vehicle or 100 nM THDOC. If the remaining IPSCslow events were mediated by extrasynaptic receptors containing subunits, there should be a change in their kinetics in the presence of THDOC; however, this was not the case because we found no significant difference between the groups (Table 2).
|
subunit–containing GABARs to the tonic currents recorded in gabra5–/– CA1 PCs. THIP (gaboxadol) is a GABA superagonist mostly at subunit–containing GABARs (Brown et al. 2002) and we used it to replace GABA in an equimolar concentration in the perfusion solution. gabra5+/+ CA1 PCs tonic currents measured under this condition were 223.3 ± 25.20 pA (n = 8), whereas the gabra5–/– CA1 PCs showed a tonic current of 170.1 ± 9.81 pA (n = 10), both statistically different from those recorded in the presence of 5 µM GABA (one-way ANOVA, both P = 1.1 x 10–5, Tukey test). A two-way ANOVA from eight randomly selected cells showed no interaction between genotype and THIP. Nevertheless, the THIP/GABA tonic current ratio for the gabra5–/– CA1 PCs was 9.88, which was statistically different from the gabra5+/+ CA1 PC tonic current ratio of 5.74 (one-way ANOVA, P = 0.0005, df = 1). To analyze the effect of THIP on phasic inhibitory currents, we had to use the largest-amplitude-count–matching method (Stell 2002) resulting from the high baseline noise in the presence of THIP that prevented the measurement of small-amplitude sIPSCs. THIP caused a statistical difference only in the RT10–90 of both genotypes when compared with 5 µM GABA (gabra5+/+ control 0.60 ± 0.02 ms vs. gabra5+/+ THIP 0.78 ± 0.03 ms, P = 0.0051; gabra5–/– control 0.63 ± 0.05 ms vs. gabra5–/– THIP 0.76 ± 0.03 ms, P = 0.0394, one-way ANOVA, from the same eight cells randomly selected to determine the ratio of THIP effect; Table 3). These results together with the effects of muscimol and THDOC show that gabra5–/– CA1 PCs have replaced the 5 subunit–containing GABARs mediating the tonic inhibition with receptors most likely containing subunits.
The GABAAR subunits are necessary for the effects of benzodiazepines (Pritchett et al. 1989). We wanted to test whether GABARs containing subunits are involved in generating tonic currents in gabra5–/– CA1 PCs. In the presence of a threshold concentration of diazepam (0.5 µM) tonic currents recorded in gabra5+/+ CA1 PCs were 60.8 ± 7.05 pA (n = 6), whereas in gabra5–/– CA1 PCs were 36.8 ± 5.13 pA (n = 7). A two-way ANOVA between six randomly selected cells showed no interaction between genotype and diazepam (P = 0.888, df = 1). There was no statistical difference between the control values and diazepam for both gabra5+/+ and gabra5–/– (gabra5+/+ control: 45.5 ± 4.67 pA; gabra5+/+ diazepam: 60.8 ± 7.05 pA; gabra5–/– control: 24.0 ± 2.64 pA; gabra5–/– diazepam: 37.8 ± 5.97 pA; P > 0.05, one-way ANOVA, Tukey test, n = 6). In contrast to its lack of effect on the tonic currents, this concentration of diazepam significantly increased the decay of sIPSCs, whereas frequency and other properties were not affected (decay: gabra5+/+ control 6.50 ± 0.11 ms vs. gabra5+/+ diazepam 7.54 ± 0.27 ms; gabra5–/– control 6.41 ± 0.22 ms vs. gabra5–/– diazepam 7.37 ± 0.35 ms; one-way ANOVA for each category, P < 0.05 for decay, n = 6, the same cells used to compare tonic currents). A two-way ANOVA showed a significant drug effect regardless of the genotype for the RT10–90 (P = 0.0386, df = 1) and decay (P = 0.0007, df = 1). Thus the low concentration of diazepam affected sIPSCs kinetics but failed to induce a statistical difference in tonic currents. The small, albeit not statistically significant, increase in the gabra5–/– tonic currents by diazepam points to a portion of the residual tonic current being mediated by GABARs containing 1–3 and subunits in addition to the diazepam-insensitive subunit–containing receptors. Perhaps this question can best be answered in a gabrad–/–/gabra5–/– double knockout mouse, which is presently unavailable.
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
5 subunits, a key component of extrasynaptic GABARs. Our results can be summarized as follows. 1) In the absence of the GABAR 5 subunits, the tonic inhibition of hippocampal CA1 and CA3 PCs is about half that found in the WT, but phasic inhibition is unaltered. 2) This specific reduction of tonic inhibition is sufficient to induce epileptiform hyperexcitability in the CA3 region that can be reversed by pharmacologically increasing the tonic current. 3) In the absence of 5 subunits, expression of GABAR subunits is responsible for the residual tonic inhibition in gabra5–/– PCs. 4) Some IPSCsslow are attributed to spillover of GABA onto extrasynaptic receptors.
There is mounting evidence for extrasynaptic GABARs having subunit compositions different from that of synaptic receptors (Brickley et al. 2001; Nusser et al. 2002; Stell et al. 2003; Wisden et al. 2002). The 5 subunit is thought of as a specific subunit forming extrasynaptic receptors in hippocampal PCs (Brünig et al. 2002; Caraiscos et al. 2004; Sperk et al. 1997). Even if present at synapses, our experiments support the exclusive participation of these subunits in the generation of tonic inhibition. The similar properties of sIPSCs and mIPSCs in CA1 and CA3 PCs in WT and gabra5–/– mice argue against the participation of 5 subunits in phasic inhibition, in contrast to a previous report where recordings were carried out at room temperature (Collinson et al. 2002). According to our results showing similar sIPSC frequencies in WT and gabra5–/– PCs, it is also unlikely that an 5 subunit–mediated tonic inhibition dampens the excitability of interneurons responsible for generating sIPSCs in PCs. Furthermore, the similar properties of mIPSCs between C57/Bl6 and gabra5–/– are consistent with the absence of any compensatory GABAR subunit changes at PC synapses in gabra5–/– animals. Taken together, our data support the idea that 5 subunits are not functional at GABA synapses on CA1 and CA3 PCs, but may be involved in generating some slow IPSCs. If 5 subunits are present at synapses, the 5-containing GABARs must be in a nonfunctional (probably desensitized) state or they may combine with other subunits (e.g., 1–3) that overshadow the properties of the 5 subunits. Thus in the gabra5–/– mice, synaptic 5 subunits may be replaced by other subunits without altering the general properties of the phasic currents. Similar to findings in rat CA1 PCs (Banks et al. 1998; Pearce 1993), we observed IPSCslow at low frequencies in CA1 and CA3 PCs of both WT and gabra5–/– mice. Their reduced ratio in gabra5–/– PCs is consistent with some IPSCslow events resulting from GABA spillover onto extrasynaptic 5 subunit–containing receptors, whereas the rest of IPSCslow events may result from GABA spillover onto extrasynaptic receptors containing other subunits. Another possibility is that some of the IPSCslow may be mediated by a specific class of interneuron as previously proposed in the rat (Banks et al. 1998, 2002). In any case, the total charge mediated by IPSCslow is minimal (about 3%) in comparison with the charge transfer caused by tonic inhibition. Therefore the decrease in the ratio of IPSCslow/total must have only a negligible contribution to the hyperexcitability found in the CA3 layer of the hippocampus.
In the absence of any changes in phasic inhibition in CA1/3 PCs, the gabra5–/– mice appear to be an ideal preparation to study the effects of selective decreases in tonic inhibition, otherwise difficult to accomplish by pharmacological means. In both CA1 and CA3 PCs of gabra5–/– mice the tonic current was about 56 and 53%, respectively, of that recorded in WT. These results are in contrast with those reported by Caraiscos et al. (2004) in CA1 PCs, where the loss of 5 subunits was paralleled by a total loss of tonic currents. In our experiments, CA1 PCs in P18 gabra5–/– mice (as used by Caraiscos et al. 2004) showed a residual tonic current in the presence of 5 µM GABA, as well as in adult gabra5–/– mice in the absence of any externally added GABA. It remains to be determined whether the difference between the two contradicting results arises from different methods used to reveal the tonic inhibition (5 µM GABA vs. vigabatrin) or from other experimental reasons. Nevertheless, based on our findings, we used hippocampal slices of gabra5–/– mice to study the effects of a specific reduction in tonic inhibition on network excitability.
The hyperexcitability found in field recordings from the CA3 pyramidal layer in gabra5–/– slices indicates that a specific reduction in tonic inhibition can tip over the balance of neuronal excitability leading to epileptiform events. In contrast, the lack of spontaneous field activity in the CA1 region of gabra5–/– slices may mean that the nearly 50% reduction in tonic inhibition is not sufficient to allow the expression of hyperexcitability in this region. Thus the residual tonic inhibition appears to be effective in maintaining normal excitability in a relatively less hyperexcitable region of the hippocampus. Consistent with its specific activation of extrasynaptic receptors of a certain subunit composition, a low concentration of muscimol (25 nM) was sufficient to significantly decrease the amplitude and frequency of the epileptiform events in CA3 region gabra5–/– slices. It is not known whether similar changes in tonic inhibition or compensatory mechanisms occur when the levels of 5 subunits become decreased in PCs in the pilocarpine model of epilepsy (Houser and Esclapez 2003; Scimemi et al. 2005). One would expect such change to lead to a compromised tonic inhibition like that we found in gabra5–/– mice. Our findings on the heightened network excitability in the face of a specific reduction of tonic inhibition are consistent with previous studies. Because extrasynaptic receptors outnumber those found at synapses (Banks and Pearce 2000; Nusser et al. 1995; Wei et al. 2003) and are activated by ambient GABA levels (Mody 2001), it is not surprising that this pool of receptors plays an important role in controlling the background inhibitory input of a cell and its gain control (Chance et al. 2002). Tonic inhibition affects the input–output function of cerebellar granule cells in vivo and in vitro (Chadderton et al. 2004; Mitchell and Silver 2003). Moreover, the 5 subunit has been shown to alter the dynamic profile of gamma oscillations to changes in network drive (Towers et al. 2004).
In a battery of pharmacological experiments, we have identified subunit–containing GABARs as the mediators of the residual tonic current in gabra5–/– PCs. The subunit has been well established as an extrasynaptic receptor in dentate and cerebellar granule cells and as a mediator of tonic currents (Nusser et al. 1998; Stell et al. 2003; Wei et al. 2003). However, only small amounts of this subunit mRNA and immunoreactivity are detectable in CA1 PCs (Fritschy and Möhler 1995; Pirker et al. 2000; Sperk et al. 1997; Wisden et al. 1992), and CA1 PC tonic currents are insensitive to the neurosteroid THDOC, which specifically enhances tonic currents where subunits are expressed (Stell et al. 2003). Consistent with these previous findings, phasic and tonic currents were unaffected by 100 nM THDOC in WT CA1 PCs. In contrast, 100 nM THDOC enhanced the tonic currents in gabra5–/– CA1 PCs by 174%. This concentration of THDOC produced a nearly 150% potentiation of the tonic currents in subunit–containing dentate gyrus granule cells and a nearly 255% increase in subunit–containing cerebellar granule cells (Stell et al. 2003). Thus THDOC potentiation of the residual tonic current recorded in the absence of 5 subunits was commensurate with its effect on cells where tonic inhibition is mediated by subunits in combination with 4 or 6 subunits. Immunostaining for subunits did not show a difference between gabra5+/+ and gabra5–/– (data not shown), probably arising from a lack of sensitivity of this method to detect small changes in subunit expression. However, our further pharmacological experiments were consistent with the compensatory upregulation of subunit–containing GABARs in the absence of 5 subunits.
Muscimol (25 nM) significantly increased tonic currents only in gabra5–/– CA1 PCs, whereas tonic currents of gabra5+/+ CA1 PCs were unaffected. Furthermore, the ratio of tonic currents recorded in THIP or GABA was significantly higher in gabra5–/– CA1 PCs than that in gabra5+/+ CA1 PCs, which also suggests a higher expression of subunits in gabra5–/– mice. The only inconsistent pharmacological finding is that threshold concentrations of diazepam (0.5 µM) that enhanced synaptic currents failed to produce a significant increase in the tonic currents of gabra5+/+ CA1 PCs. This would be expected from a lower diazepam sensitivity of an 5/ subunit containing extrasynaptic GABARs than that at the synapses or the concentration of extracellular GABA is not high enough to fully activate diazepam-sensitive receptors. Our combined pharmacological evidence strongly suggests that in the absence of 5 subunits, a residual tonic current in both CA1 and CA3 PCs is mediated by the GABARs containing subunits, possibly in combination with 4 subunits. The compensation for the tonic current is not full and the decreased tonic inhibition translates into network hyperexcitability in the CA3 region of gabra5–/– mice.
While experimenting with optimal methods for slice storage and recording, we also discovered a significant effect of the slice storage conditions specifically affecting the tonic currents recorded in WT PCs. The larger tonic currents recorded in gabra5+/+ slices, but not in gabra5–/– slices, stored in an interface chamber compared with those stored in a submerged chamber, mean that specific conditions in the interface chamber favor the activation of 5 subunit–containing receptors. A decreased GABA uptake, an altered phosphorylation/dephosphorylation process, or a lower metabolical distress of the cells in the interface chamber may all affect the activation of 5 subunit–containing GABARs. The lack of statistical difference between tonic currents in gabra5–/– slices stored in the two different storage chambers could be a result of the different properties of the receptors mediating tonic currents in the absence of 5 subunits. Regardless of the mechanisms, our studies identify slice storage conditions as an important factor in controlling the amount of tonic inhibition present in hippocampal PCs.
Interestingly, the gabra5–/– mice have been shown to perform better in various learning and memory tests (Collinson et al. 2002). If indeed the tonic inhibition mediated by 5 subunit–containing GABARs impedes learning and memory, there might have been an evolutionary pressure to diminish the levels of this subunit, especially because the 5 distribution in the adult brain is very restricted. One possible reason for the enduring presence of 5 subunits in hippocampal PCs could be that the advantages in learning/memory stemming from its loss may be counterbalanced by a hyperexcitable epileptic phenotype. The 5 subunit has also been found in the human hippocampus with a distinct localization to the CA1 and CA3 regions (Wainwright et al. 2000). The ability to modulate tonic inhibition mediated by these receptors by specific pharmacological means may allow striking a balance between the needs for increased excitation required for better learning and those for controlling the hyperexcitability.
|
GRANTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
|
ACKNOWLEDGMENTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
|
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: I. Mody, UCLA School of Medicine, Department of Neurology, Neuroscience Research Building Room 571, 635 Charles E. Young Dr. South, Los Angeles, CA 90095 (E-mail: mody{at}ucla.edu)
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONGRANTSACKNOWLEDGMENTSREFERENCES |
|---|
Banks MI, Hardie JB, and Pearce RA. Development of GABA(A) receptor-mediated inhibitory postsynaptic currents in hippocampus. J Neurophysiol 88: 3097–3107, 2002.
Banks MI, Li TB, and Pearce RA. The synaptic basis of GABAA,slow. Neuroscience 18: 1305–1317, 1998.[Medline]
Banks MI and Pearce RA. Kinetic differences between synaptic and extrasynaptic GABA(A) receptors in CA1 pyramidal cells. Neuroscience 20: 937–948, 2000.[Medline]
Brickley SG, Cull-Candy SG, and Farrant M. Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J Physiol 497: 753–759, 1996.
Brickley SG, Revilla V, Cull-Candy SG, Wisden W, and Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409: 88–92, 2001.[CrossRef][Medline]
Brown N, Kerby J, Bonnert TP, Whiting PJ, and Wafford KA. Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors. Br J Pharmacol 136: 965–974, 2002.[CrossRef][Web of Science][Medline]
Brünig I, Scotti E, Sidler C, and Fritschy JM. Intact sorting, targeting, and clustering of gamma-aminobutyric acid A receptor subtypes in hippocampal neurons in vitro. J Comp Neurol 443: 43–55, 2002.[CrossRef][Web of Science][Medline]
Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, Newell JG, Jackson MF, Lambert JJ, Rosahl TW, Wafford KA, MacDonald JF, and Orser BA. Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 101: 3662–3667, 2004.
Chadderton P, Margrie TW, and Hausser M. Integration of quanta in cerebellar granule cells during sensory processing. Nature 428: 856–860, 2004.[CrossRef][Medline]
Chance FS, Abbott LF, and Reyes AD. Gain modulation from background synaptic input. Neuron 35: 773–782, 2002.[CrossRef][Web of Science][Medline]
Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, Smith A, Otu FM, Howell O, Atack JR, McKernan RM, Seabrook GR, Dawson GR, Whiting PJ, and Rosahl TW. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha5 subunit of the GABAA receptor. Neuroscience 22: 5572–5580, 2002.[Medline]
Colom LV and Saggau P. Spontaneous interictal-like activity originates in multiple areas of the CA2–CA3 region of hippocampal slices. J Neurophysiol 71: 1574–1585, 1994.
Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Bluthmann H, Mohler H, and Rudolph U. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci USA 99: 8980–8985, 2002.
Ding R, Asada H, and Obata K. Changes in extracellular glutamate and GABA levels in the hippocampal CA3 and CA1 areas and the induction of glutamic acid decarboxylase-67 in dentate granule cells of rats treated with kainic acid. Brain Res 800: 105–113, 1998.[CrossRef][Web of Science][Medline]
Farrant M and Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6: 215–229, 2005.[CrossRef][Web of Science][Medline]
Fritschy JM and Möhler H. GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359: 154–194, 1995.[CrossRef][Web of Science][Medline]
Hevers W and Lüddens H. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 18: 35–86, 1998.[Web of Science][Medline]
Houser CR and Esclapez M. Downregulation of the alpha5 subunit of the GABA(A) receptor in the pilocarpine model of temporal lobe epilepsy. Hippocampus 13: 633–645, 2003.[CrossRef][Web of Science][Medline]
Krimer L and Goldman-Rakic. An interface holding chamber for anatomical and physiological studies of living brain slices. J Neurosci Methods 75: 55–58, 1997.[CrossRef][Web of Science][Medline]
Laurie DJ, Wisden W, and Seeburg PH. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. Neuroscience 12: 4151–4172, 1992.[Medline]
Lerma J, Herranz AS, Herreras O, Abraira V, and Martin del Rio R. In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis. Brain Res 384: 145–155, 1986.[CrossRef][Web of Science][Medline]
Maier N, Nimmrich V, and Draguhn A. Cellular and network mechanisms underlying spontaneous sharp wave-ripple complexes in mouse hippocampal slices. J Physiol 550: 873–-887, 2003.
Mihalek RM, Banerjee PK, Korpi ER, Quinlan JJ, Firestone LL, Mi ZP, Lagenaur C, Tretter V, Sieghart W, Anagnostaras SG, Sage JR, Fanselow MS, Guidotti A, Spigelman I, Li Z, DeLorey TM, Olsen RW, and Homanics GE. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci USA 96: 12905–12910, 1999.
Mitchell SJ and Silver RA. Shunting inhibition modulates neuronal gain during synaptic excitation. Neuron 38: 433–445, 2003.[CrossRef][Web of Science][Medline]
Mody I. Distinguishing between GABAA receptors responsible for tonic and phasic conductances. Neurochem Res 26: 907–913, 2001.[CrossRef][Web of Science][Medline]
Nagao T, Alonso A, and Avoli M. Epileptiform activity induced by pilocarpine in the rat hippocampal-entorhinal slice preparation. Neuroscience 72: 399–408, 1996.[CrossRef][Web of Science][Medline]
Nusser Z and Mody I. Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells. J Neurophysiol 87: 2624–2628, 2002.
Nusser Z, Roberts JD, Baude A, Richards JG, and Somogyi P. Relative densities of synaptic and extrasynaptic GABAA receptors on cerebellar granule cells as determined by a quantitative immunogold method. Neuroscience 15: 2948–2960, 1995.[Medline]
Nusser Z, Sieghart W, and Somogyi P. Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. Neuroscience 18: 1693–1703, 1998.[Medline]
Pearce RA. Physiological evidence for two distinct GABAA responses in rat hippocampus. Neuron 10: 189–200, 1993.[CrossRef][Web of Science][Medline]
Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, and Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101: 815–850, 2000.[CrossRef][Web of Science][Medline]
Pritchett DB, Sontheimer H, Shivers BD, Ymer S, Kettenmann H, Schofield PR, and Seeburg PH. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature 338: 582–585, 1989.[CrossRef][Medline]
Ramos B, Lopez-Tellez JF, Vela J, Baglietto-Vargas D, del Rio JC, Ruano D, Gutierrez A, and Vitorica J. Expression of alpha 5 GABAA receptor subunit in developing rat hippocampus. Brain Res Dev Brain Res 151: 87–98, 2004.[Medline]
Rice A, Rafiq A, Shapiro SM, Jakoi ER, Coulter DA, and DeLorenzo RJ. Long-lasting reduction of inhibitory function and gamma-aminobutyric acid type A receptor subunit mRNA expression in a model of temporal lobe epilepsy. Proc Natl Acad Sci USA 93: 9665–9669, 1996.
Rossi DJ, Hamann M, and Attwell D. Multiple modes of GABAergic inhibition of rat cerebellar granule cells. J Physiol 548: 97–110, 2003.
Saxena NC, Neelands TR, and Macdonald RL. Contrasting actions of lanthanum on different recombinant gamma-aminobutyric acid receptor isoforms expressed in L929 fibroblasts. Mol Pharmacol 51: 328–335, 1997.
Scimemi A, Semyanov A, Sperk G, Kullmann DM, and Walker MC. Multiple and plastic receptors mediate tonic GABAA receptor currents in the hippocampus. Neuroscience 25: 10016–10024, 2005.[Medline]
Semyanov A, Walker MC, and Kullmann DM. GABA uptake regulates cortical excitability via cell type-specific tonic inhibition. Nat Neurosci 6: 484–490, 2003.[Web of Science][Medline]
Semyanov A, Walker MC, Kullmann DM, and Silver RA. Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci 27: 262–269, 2004.[CrossRef][Web of Science][Medline]
Shen H, Gong QH, Yuan M, and Smith SS. Short-term steroid treatment increases delta GABA(A) receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 49: 573–586, 2005.[Web of Science][Medline]
Sieghart W and Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2: 795–816, 2002.[CrossRef][Medline]
Sperk G, Schwarzer C, Tsunashima K, Fuchs K, and Sieghart W. GABA(A) receptor subunits in the rat hippocampus. I. Immunocytochemical distribution of 13 subunits. Neuroscience 80: 987–1000, 1997.[CrossRef][Web of Science][Medline]
Stell BM, Brickley SG, Tang CY, Farrant M, and Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors. Proc Natl Acad Sci USA 100: 14439–14444, 2003.
Stell BM and Mody I. Receptors with different affinities mediate phasic and tonic GABA(A) conductances in hippocampal neurons. Neuroscience 22: RC223, 2002.[Medline]
Sur C, Fresu L, Howell O, McKernan RM, and Atack JR. Autoradiographic localization of alpha5 subunit-containing GABAA receptors in rat brain. Brain Res 822: 265–270, 1999.[CrossRef][Web of Science][Medline]
Tossman U, Jonsson G, and Ungerstedt U. Regional distribution and extracellular levels of amino acids in rat central nervous system. Acta Physiol Scand 127: 533–545, 1986.[Web of Science][Medline]
Towers SK, Gloveli T, Traub RD, Driver JE, Engel D, Fradley R, Rosahl TW, Maubach K, Buhl EH, and Whittington MA. Alpha 5 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in vitro. J Physiol 559: 721–728, 2004.
Wainwright A, Sirinathsinghji DJ, and Oliver KR. Expression of GABA(A) receptor alpha5 subunit-like immunoreactivity in human hippocampus. Brain Res Mol Brain Res 80: 228–232, 2000.[Medline]
Wallner M, Hanchar HJ, and Olsen RW. Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci USA 100: 15218–15223, 2003.
Wei W, Faria LC, and Mody I. Low ethanol concentrations selectively augment the tonic inhibition mediated by delta subunit-containing GABAA receptors in hippocampal neurons. Neuroscience 24: 8379–8382, 2004.[Medline]
Wei W, Zhang N, Peng Z, Houser CR, and Mody I. Perisynaptic localization of delta subunit-containing GABA(A) receptors and their activation by GABA spillover in the mouse dentate gyrus. Neuroscience 23: 10650–10661, 2003.[Medline]
Wisden W, Cope D, Klausberger T, Hauer B, Sinkkonen ST, Tretter V, Lujan R, Jones A, Korpi ER, Mody I, Sieghart W, and Somogyi P. Ectopic expression of the GABA(A) receptor alpha6 subunit in hippocampal pyramidal neurons produces extrasynaptic receptors and an increased tonic inhibition. Neuropharmacology 43: 530–549, 2002.[CrossRef][Web of Science][Medline]
Wisden W, Laurie DJ, Monyer H, and Seeburg PH. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. Neuroscience 12: 1040–1062, 1992.[Medline]
This article has been cited by other articles:
|
|
 |
|
  G. Curia, T. Papouin, P. Seguela, and M. Avoli Downregulation of Tonic GABAergic Inhibition in a Mouse Model of Fragile X Syndrome Cereb Cortex, July 1, 2009; 19(7): 1515 - 1520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Zarnowska, R. Keist, U. Rudolph, and R. A. Pearce GABAA Receptor {alpha}5 Subunits Contribute to GABAA,slow Synaptic Inhibition in Mouse Hippocampus J Neurophysiol, March 1, 2009; 101(3): 1179 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Andrasfalvy, J. K. Makara, D. Johnston, and J. C. Magee Altered synaptic and non-synaptic properties of CA1 pyramidal neurons in Kv4.2 knockout mice J. Physiol., August 15, 2008; 586(16): 3881 - 3892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Glykys, E. O. Mann, and I. Mody Which GABAA Receptor Subunits Are Necessary for Tonic Inhibition in the Hippocampus? J. Neurosci., February 6, 2008; 28(6): 1421 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Eugene, C. Depienne, S. Baulac, M. Baulac, J. M. Fritschy, E. Le Guern, R. Miles, and J. C. Poncer GABAA Receptor {gamma}2 Subunit Mutations Linked to Human Epileptic Syndromes Differentially Affect Phasic and Tonic Inhibition J. Neurosci., December 19, 2007; 27(51): 14108 - 14116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Bonin, L. J. Martin, J. F. MacDonald, and B. A. Orser {alpha}5GABAA Receptors Regulate the Intrinsic Excitability of Mouse Hippocampal Pyramidal Neurons J Neurophysiol, October 1, 2007; 98(4): 2244 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Szabadics, G. Tamas, and I. Soltesz Different transmitter transients underlie presynaptic cell type specificity of GABAA,slow and GABAA,fast PNAS, September 11, 2007; 104(37): 14831 - 14836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Gray and B. L. Roth Molecular Targets for Treating Cognitive Dysfunction in Schizophrenia Schizophr Bull, September 1, 2007; 33(5): 1100 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Glykys and I. Mody The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus J. Physiol., August 1, 2007; 582(3): 1163 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Zhang, W. Wei, I. Mody, and C. R. Houser Altered Localization of GABAA Receptor Subunits on Dentate Granule Cell Dendrites Influences Tonic and Phasic Inhibition in a Mouse Model of Epilepsy J. Neurosci., July 11, 2007; 27(28): 7520 - 7531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Nahir, C. Bhatia, and C. J. Frazier Presynaptic Inhibition of Excitatory Afferents to Hilar Mossy Cells J Neurophysiol, June 1, 2007; 97(6): 4036 - 4047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Gorter, E. A. van Vliet, E. Aronica, T. Breit, H. Rauwerda, F. H. Lopes da Silva, and W. J. Wadman Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe Epilepsy J. Neurosci., October 25, 2006; 26(43): 11083 - 11110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Andrasfalvy and I. Mody Differences between the scaling of miniature IPSCs and EPSCs recorded in the dendrites of CA1 mouse pyramidal neurons J. Physiol., October 1, 2006; 576(1): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
, right). Difference was not statistically different (one-way ANOVA, P = 0.9734, Tukey test). B: same as A, but recorded from a gabra5–/– CA1 PC. Difference in tonic current between aCSF and 25 nM muscimol was statistically different (one-way ANOVA, P = 0.0003, Tukey test). C: superimposed averaged sIPSCs from a single gabra5+/+ CA1 PC in the presence of aCSF and 25 nM muscimol (arrow). D: same as C but recorded from a single gabra5–/– CA1 PC. Frequency and kinetics of sIPSCs were not statistically different between muscimol and regular aCSF in both gabra5+/+ and gabra5–/– (one-way ANOVA, P > 0.05, Tukey test).
